176 related articles for article (PubMed ID: 22569198)
21. pLDH level of clinically isolated Plasmodium vivax and detection limit of pLDH based malaria rapid diagnostic test.
Jang JW; Cho CH; Han ET; An SS; Lim CS
Malar J; 2013 Jun; 12():181. PubMed ID: 23731660
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the sensitivity of a pLDH-based and an aldolase-based rapid diagnostic test for diagnosis of uncomplicated and severe malaria caused by PCR-confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivax.
Barber BE; William T; Grigg MJ; Piera K; Yeo TW; Anstey NM
J Clin Microbiol; 2013 Apr; 51(4):1118-23. PubMed ID: 23345297
[TBL] [Abstract][Full Text] [Related]
23. Serologic and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs.
Kain KC; Wirtz RA; Fernandez I; Franke ED; Rodriguez MH; Lanar DE
Am J Trop Med Hyg; 1992 Apr; 46(4):473-9. PubMed ID: 1575295
[TBL] [Abstract][Full Text] [Related]
24. Probability of antibody formation against circumsporozoite protein of Plasmodium vivax among Korean malaria patients.
Nam HW; Song KJ; Ahn HJ; Yang Z; Chong CK; Cho PY; Ahn SK; Kim TS
Korean J Parasitol; 2014 Apr; 52(2):143-9. PubMed ID: 24850957
[TBL] [Abstract][Full Text] [Related]
25. Genetic diversity of Plasmodium vivax and Plasmodium falciparum lactate dehydrogenases in Myanmar isolates.
Lee J; Kim TI; Lê HG; Yoo WG; Kang JM; Ahn SK; Myint MK; Lin K; Kim TS; Na BK
Malar J; 2020 Feb; 19(1):60. PubMed ID: 32019541
[TBL] [Abstract][Full Text] [Related]
26. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).
Alam MT; Bora H; Singh N; Sharma YD
Vaccine; 2008 Jul; 26(31):3787-94. PubMed ID: 18579264
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of the merozoite surface protein 1 of Plasmodium vivax as an antigen for ELISA to diagnose malaria.
Kim YM; Hwang HA; Yun WS; Kim SI; Lee KW; Park SK; Lee YJ; Kim TK; Wongsrichanalai C; Sakanari JA; Park H
Yonsei Med J; 2004 Feb; 45(1):129-34. PubMed ID: 15004879
[TBL] [Abstract][Full Text] [Related]
28. Characterizing PvARP, a novel Plasmodium vivax antigen.
Moreno-Pérez DA; Saldarriaga A; Patarroyo MA
Malar J; 2013 May; 12():165. PubMed ID: 23688042
[TBL] [Abstract][Full Text] [Related]
29. Genetic characteristics of polymorphic antigenic markers among Korean isolates of Plasmodium vivax.
Hwang SY; Kim SH; Kho WG
Korean J Parasitol; 2009 Oct; 47 Suppl(Suppl):S51-8. PubMed ID: 19885335
[TBL] [Abstract][Full Text] [Related]
30. A panel of recombinant proteins from human-infective Plasmodium species for serological surveillance.
Müller-Sienerth N; Shilts J; Kadir KA; Yman V; Homann MV; Asghar M; Ngasala B; Singh B; Färnert A; Wright GJ
Malar J; 2020 Jan; 19(1):31. PubMed ID: 31952523
[TBL] [Abstract][Full Text] [Related]
31. Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).
Moreno-Perez DA; Montenegro M; Patarroyo ME; Patarroyo MA
Malar J; 2011 Oct; 10():314. PubMed ID: 22024312
[TBL] [Abstract][Full Text] [Related]
32. Humoral immune responses to a recombinant Plasmodium vivax tryptophan-rich antigen among Plasmodium vivax-infected patients and its localization in the parasite.
Siddiqui AA; Khan F; Sharma YD
Appl Biochem Biotechnol; 2015 Feb; 175(4):2166-77. PubMed ID: 25467946
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.
Kang JM; Ju HL; Kang YM; Lee DH; Moon SU; Sohn WM; Park JW; Kim TS; Na BK
Malar J; 2012 Jun; 11():206. PubMed ID: 22709605
[TBL] [Abstract][Full Text] [Related]
34. Plasmodium vivax merozoite surface proteins-3beta and-3gamma share structural similarities with P. vivax merozoite surface protein-3alpha and define a new gene family.
Galinski MR; Ingravallo P; Corredor-Medina C; Al-Khedery B; Povoa M; Barnwell JW
Mol Biochem Parasitol; 2001 Jun; 115(1):41-53. PubMed ID: 11377738
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar.
Kim TS; Kim HH; Kim JY; Kong Y; Na BK; Lin K; Moon SU; Kim YJ; Kwon MH; Sohn Y; Kim H; Lee HW
Malar J; 2011 Aug; 10():228. PubMed ID: 21819610
[TBL] [Abstract][Full Text] [Related]
36. Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients.
Nateghpour M; Etemadi S; Motevalli Haghi A; Eslami H; Mohebali M; Farivar L
Eur J Med Res; 2021 Nov; 26(1):134. PubMed ID: 34823591
[TBL] [Abstract][Full Text] [Related]
37. Surveillance on the Vivax Malaria in Endemic Areas in the Republic of Korea Based on Molecular and Serological Analyses.
Lee SK; Hu F; Firdaus ER; Park JH; Han JH; Lee SE; Shin HI; Cho SH; Park WS; Lu F; Han ET
Korean J Parasitol; 2020 Dec; 58(6):609-617. PubMed ID: 33412764
[TBL] [Abstract][Full Text] [Related]
38. Combined Use of Malaria Antigen and Antibody Enzyme-Linked Immunosorbent Assay for Blood Screening of Plasmodium vivax in the Republic of Korea.
Kim J; Jang JW; Kim JY; Oh DJ; Lim CS
Med Princ Pract; 2016; 25(3):212-8. PubMed ID: 26794404
[TBL] [Abstract][Full Text] [Related]
39. Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax.
Njuguna JT; Nassar M; Hoerauf A; Kaiser AE
BMC Microbiol; 2006 Oct; 6():91. PubMed ID: 17042947
[TBL] [Abstract][Full Text] [Related]
40. ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas.
Kim S; Ahn HJ; Kim TS; Nam HW
Korean J Parasitol; 2003 Dec; 41(4):203-7. PubMed ID: 14699261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
